Skip to main content

ACADIAN ASSET MANAGEMENT LLC

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 916542 Boston, MA

Position in BCRX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$626,570
-$1,087,125 QoQ
Shares Held
62,657
-65.2% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#146
of 316 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $533,943,071 across 32 Drug Manufacturers - Specialty & Generic names. BCRX ranks #24 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BCRX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $626,570 62,657
2026-03-31 $1,713,695 180,010
2025-12-31 $665,340 85,300
2025-09-30 $6,371,068 839,403
2025-06-30 $3,331,077 371,772
2025-03-31 $5,027,707 670,361
2024-12-31 $1,464,873 194,797
2024-09-30 $86,070 11,325
2020-06-30 $75,836 15,932
2020-03-31 $383,528 191,764